Our Medicines

Through development and commercialization partnerships, Sosei Heptares has already delivered two products to treat chronic obstructive pulmonary disease (COPD) and an emergency contraceptive to market. The legacy Novartis franchise continues to generate significant and stable revenue streams that enable further growth of the business.